Status:
UNKNOWN
Effect of Target Fortified Human Milk on the Growth Quality of Very Preterm Infants (TargetFort)
Lead Sponsor:
Centro Hospitalar de Lisboa Central
Collaborating Sponsors:
Sociedade Portuguesa de Neonatologia
Conditions:
Growth
Body Composition
Eligibility:
All Genders
1+ years
Brief Summary
It is reported that the standard method for fortification of human milk (HM) overestimates the energy and protein densities of HM (Macedo MHNP 2018), thus originating infant undernutrition (Macedo AJP...
Detailed Description
Study design: observational mixed cohort study, comparing growth and body composition in a contemporary cohort of very preterm infants fed HM with target fortification, the currently adopted clinical ...
Eligibility Criteria
Inclusion
- newborn infants born at \<33 weeks of gestation,
- admitted to the NICU of Maternidade Dr. Alfredo da Costa (inborns and outborns),
- exclusively or predominantly HM fed (\>87.5% volume per day)
- discharged alive.
Exclusion
- multiples of grade \>2
- diagnosis of innate metabolism disorder,
- fed with formula for \>12.5% of the daily volume intake for two or more consecutive full days ,
- discharge with transference to other hospital,
- unavailable for body composition analysis after discharge.
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 16 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04400396
Start Date
February 1 2020
End Date
December 16 2021
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Hospitalar Universitário de Lisboa Central
Lisbon, Portugal, 1150-199